Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Genmab
Genmab
Hoffmann-La Roche
Ohio State University Comprehensive Cancer Center
Regeneron Pharmaceuticals
Mayo Clinic
University of Wisconsin, Madison
Massachusetts General Hospital
University of Michigan Rogel Cancer Center
Fred Hutchinson Cancer Center
Sana Biotechnology
M.D. Anderson Cancer Center
City of Hope Medical Center
Sana Biotechnology
Fred Hutchinson Cancer Center
Incyte Corporation
Jonsson Comprehensive Cancer Center
University of Rochester
University Hospital Southampton NHS Foundation Trust
City of Hope Medical Center
University of Chicago
City of Hope Medical Center
Synthekine
Shanghai Ming Ju Biotechnology Co., Ltd.
Genmab
Chipscreen Biosciences, Ltd.
Peter MacCallum Cancer Centre, Australia